134 related articles for article (PubMed ID: 24370868)
1. DNA vaccines for HFRS: laboratory and clinical studies.
Schmaljohn CS; Spik KW; Hooper JW
Virus Res; 2014 Jul; 187():91-6. PubMed ID: 24370868
[TBL] [Abstract][Full Text] [Related]
2. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters.
Spik KW; Badger C; Mathiessen I; Tjelle T; Hooper JW; Schmaljohn C
Vaccine; 2008 Sep; 26(40):5177-81. PubMed ID: 18482782
[TBL] [Abstract][Full Text] [Related]
3. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
4. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
[TBL] [Abstract][Full Text] [Related]
5. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
Hooper JW; Josleyn M; Ballantyne J; Brocato R
Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
Hooper JW; Custer DM; Thompson E; Schmaljohn CS
J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a multi-epitope DNA vaccine against hantavirus.
Zhao C; Sun Y; Zhao Y; Wang S; Yu T; Du F; Yang XF; Luo E
Hum Vaccin Immunother; 2012 Feb; 8(2):208-15. PubMed ID: 22426376
[TBL] [Abstract][Full Text] [Related]
8. Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.
Brocato RL; Josleyn MJ; Wahl-Jensen V; Schmaljohn CS; Hooper JW
Clin Vaccine Immunol; 2013 Feb; 20(2):218-26. PubMed ID: 23239797
[TBL] [Abstract][Full Text] [Related]
9. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
[TBL] [Abstract][Full Text] [Related]
10. The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China.
Li Z; Zeng H; Wang Y; Zhang Y; Cheng L; Zhang F; Lei Y; Jin B; Ma Y; Chen L
Hum Vaccin Immunother; 2017 Apr; 13(4):802-807. PubMed ID: 27824286
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of N-protein of Puumala hantavirus for noninbred mice in the intramuscular administration of its gene DNA].
Chubukova OV; Khasanova SS; Nikonorov IuM; Kulagin VF; Chemeris AV; Vakhitov VA
Vopr Virusol; 2008; 53(4):38-41. PubMed ID: 18756816
[TBL] [Abstract][Full Text] [Related]
12. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
Chu YK; Jennings GB; Schmaljohn CS
J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542
[TBL] [Abstract][Full Text] [Related]
13. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
Hooper JW; Custer DM; Smith J; Wahl-Jensen V
Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
[TBL] [Abstract][Full Text] [Related]
14. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
[TBL] [Abstract][Full Text] [Related]
15. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
[TBL] [Abstract][Full Text] [Related]
16. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies.
Higa MM; Petersen J; Hooper J; Doms RW
Virology; 2012 Feb; 423(2):134-42. PubMed ID: 22209230
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].
Ruan Y; Liu W; Xu X; Weng SQ; Shao SK; Zhou WQ; Teng Z; Gu HX; Zhu ZY; Xu ZY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):274-6. PubMed ID: 11986705
[TBL] [Abstract][Full Text] [Related]
18. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
[TBL] [Abstract][Full Text] [Related]
19. A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.
Yu L; Bai W; Wu X; Zhang L; Zhang L; Li P; Wang F; Liu Z; Zhang F; Xu Z
Virol J; 2013 Oct; 10():301. PubMed ID: 24093752
[TBL] [Abstract][Full Text] [Related]
20. [Long term epidemiological effects of vaccination on hemorrhagical fever with renal syndrome (HFRS) in Shaanxi provincial HFRS epidemic areas].
Wang JJ; Wei ZZ; Wei J; Ma CA; Dong JH; Lu XL; Zheng Y; Yu PB; Qu JH; Dong LF
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):309-12. PubMed ID: 22613385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
